Related Experiment Video
Updated: Mar 31, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Pathogenesis of endothelial cell dysfunction in chronic kidney disease: a retrospective and what the future may hold
1Departments of Medicine, Pharmacology and Physiology, Renal Research Institute, New York Medical College, Valhalla, NY, USA ; Departments of Pharmacology and Physiology, Pharmacology and Physiology, Renal Research Institute, New York Medical College, Valhalla, NY, USA.
Insights
Cardiovascular complications in chronic kidney disease (CKD) are linked to endothelial cell dysfunction (ECD). Research reveals premature cell aging and a shift in cell type as key factors in ECD development, with potential therapeutic targets identified.
Area of Science:
- Nephrology
- Cardiology
- Vascular Biology
Background:
- Cardiovascular complications are a leading cause of mortality in chronic kidney disease (CKD).
- Endothelial cell dysfunction (ECD) is a significant contributor to cardiovascular morbidity in CKD patients.
- ECD develops frequently in individuals with CKD.
Purpose of the Study:
- To provide an overview of endothelial cell dysfunction (ECD) in chronic kidney disease (CKD).
- To summarize two decades of laboratory research on ECD in CKD, including genetic, proteomic, and metabolomic findings.
- To discuss the clinical utility and therapeutic options for managing ECD in CKD.
Main Methods:
- Genetic analyses
- Proteomic and metabolomic screens
- Laser-Doppler flowmetry and imaging in CKD patients
Main Results:
- Detailed findings on premature senescence of endothelial cells in CKD.
- Evidence of endothelial-to-mesenchymal transition in CKD.
- Characterization of ECD developmental stages in CKD.
- Demonstrated clinical utility of flowmetry and imaging for ECD assessment.
Conclusions:
- Endothelial cell dysfunction, characterized by premature senescence and phenotypic transition, is a critical factor in CKD-related cardiovascular complications.
- Clinical assessment tools and emerging therapies show promise for managing ECD in CKD patients.
Abstract:
Cardiovascular complications dominate the landscape of chronic kidney diseases (CKD). Endothelial cell dysfunction (ECD) is a well-known culprit of cardiovascular morbidity and it develops in CKD with remarkable frequency. This brief overview of ECD in CKD scans two decades of studies performed in my laboratory, from genetic analyses to proteomic and metabolomics screens. I provide a detailed description of findings related to the premature senescence of endothelial cells, cell transition from the endothelial to mesenchymal phenotype, and stages of development of ECD. Clinical utility of some of these findings is illustrated with data on laser-Doppler flowmetry and imaging in patients with CKD. Some currently available and emerging therapeutic options for the management of ECD are briefly presented.
More Related Videos
Related Concept Videos
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease III: Interprofessional Care
Nephrons
Acute Kidney Injury II: Pathophysiology
Chronic Kidney Disease IV: Nursing Management

